Aemetis (NASDAQ:AMTX) Stock Crosses Below 200-Day Moving Average of $4.33

Aemetis, Inc. (NASDAQ:AMTX)’s stock price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $4.33 and traded as low as $3.60. Aemetis shares last traded at $3.63, with a volume of 716,903 shares changing hands.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Stifel Nicolaus cut their target price on shares of Aemetis from $8.00 to $6.50 and set a “buy” rating on the stock in a research note on Wednesday, February 21st. Truist Financial dropped their price target on shares of Aemetis from $5.00 to $3.50 and set a “hold” rating on the stock in a research note on Tuesday, January 23rd.

Aemetis Trading Up 0.5 %

The firm has a market cap of $167.03 million, a P/E ratio of -2.97 and a beta of 1.01. The business’s fifty day moving average price is $4.11 and its two-hundred day moving average price is $4.33.

Aemetis (NASDAQ:AMTX) last posted its quarterly earnings results on Thursday, March 7th. The specialty chemicals company reported ($0.34) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.35) by $0.01. The company had revenue of $70.76 million during the quarter, compared to analyst estimates of $80.08 million. During the same quarter in the prior year, the business earned ($0.63) earnings per share. Research analysts predict that Aemetis, Inc. will post -1.6 EPS for the current fiscal year.

Hedge Funds Weigh In On Aemetis

Several institutional investors have recently added to or reduced their stakes in AMTX. Barclays PLC acquired a new position in Aemetis during the third quarter valued at approximately $150,000. Sonora Investment Management Group LLC acquired a new position in shares of Aemetis in the third quarter valued at approximately $166,000. Citigroup Inc. boosted its holdings in shares of Aemetis by 10,391.3% in the third quarter. Citigroup Inc. now owns 75,013 shares of the specialty chemicals company’s stock valued at $311,000 after buying an additional 74,298 shares during the period. Finally, Stifel Financial Corp lifted its position in shares of Aemetis by 58.0% in the third quarter. Stifel Financial Corp now owns 691,445 shares of the specialty chemicals company’s stock worth $2,870,000 after purchasing an additional 253,745 shares in the last quarter. 27.02% of the stock is owned by institutional investors.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.